Canonical: https://ownershiptrace.com/13f/companies/633

# Who owns Vaxcyte, Inc. (PCVX)? Elite investor 13F holders

5 tracked elite investors reported holding Vaxcyte, Inc as of 2026-06-30, including D.E. Shaw, Caligan Partners, Maverick Capital, Renaissance Technologies LLC, Bridgewater Associates. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

5 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent carrier-sparing investigational pneumococcal conjugate vaccine (PCV) for the prevention of invasive pneumococcal disease (IPD) in infants. The company also develops VAX-31, a 31-valent,…

## Reported holders and securities, including exits (up to 20)

| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|  --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| [D.E. Shaw](https://ownershiptrace.com/13f/investors/98) | VAXCYTE INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 110555819.00 USD | 1901872.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1009207/0001104659-26-097217-index.html) |
| [Caligan Partners](https://ownershiptrace.com/13f/investors/125) | VAXCYTE INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 127225411.00 USD | 2188636.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/1727492/0001420506-26-001809-index.html) |
| [Maverick Capital](https://ownershiptrace.com/13f/investors/50) | VAXCYTE INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 93777757.00 USD | 1613242.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/934639/0000947871-26-000793-index.html) |
| [Baupost Group](https://ownershiptrace.com/13f/investors/70) | VAXCYTE INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | [Original filing](https://www.sec.gov/Archives/edgar/data/1061768/0001061768-26-000010-index.html) |
| [Renaissance Technologies LLC](https://ownershiptrace.com/13f/investors/63) | VAXCYTE INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 1141324.00 USD | 19634.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1037389/0001037389-26-000059-index.html) |
| [Bridgewater Associates](https://ownershiptrace.com/13f/investors/8) | VAXCYTE INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 2919114.00 USD | 50217.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/1350694/0001350694-26-000003-index.html) |

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

[How to read the data](https://ownershiptrace.com/docs#reading-the-data) · [Disclaimer](https://ownershiptrace.com/disclaimer)